Home | Accelerate@Babraham | Meet the experts | Peter Crane

Peter Crane

Venture Partner / Corporate Strategy, Luminous Ventures / Synthace Ltd

Peter is a scientist, who a couple of years ago made the plunge into the world of technology. As such, he approaches the world of technology investing scientifically with a focus on evidence, rather than euphoria. Whilst, the language, timings and inflexions in deep technology companies may differ to those in therapeutics; understanding of the patient or customer need, and a clear capital efficient plan to de-risk are commonalities.

He currently works in corporate strategy at Synthace (a series-B software/ SynBio company) where he leads the go-to-market in cell & gene therapy, international expansion and market thought leadership. He is also a Venture Partner at Luminous Ventures, a Pan-EU deep technology fund with a focus on life-sciences, agritech and software platforms.

Before, his current roles Peter obtained a DPhil in Chemical Biology from Oxford University, an MChem from Warwick University, experience in biopharma R&D and spent over a year working in a pharma investing role.

Having been involved in many accelerators during his studies (and benefiting massively from them), Peter is passionate about giving back to the early stage healthcare/life-sciences ecosystem, wherever possible.

Contact us


(+44) 1223 496 000

Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom

Press Enquiries

01223 813 557

Subscribe to our mailing list

Please enter your first name
Please enter your surname
Please enter your email address
; ;